Alglucosidase alfa is a recombinant human GAA (rhGAA) produced in CHO cells that is used as enzyme replacement therapy (ERT) for Pompe disease since 2006. This evidence concerns the gene GAA and Glycogen storage disease due to acid maltase deficiency.